Lexington, MA 11/27/17—Quanterix, a provider of an ultra-sensitive digital platform for life science and potentially diagnostics, has priced its IPO (see IBO 11/15/17) at $14–$16 per share. The stock will list on the NASDAQ stock exchange. The company stated it will use the net proceeds to expand operations, improve its technology, launch a new system (see Conferences), pursue regulatory approvals and potentially make acquisitions.

The IPO is expected to raise $61.5 million, according to the Boston Business Journal. The company will offer 3,340,000 shares of common stock, with a 30-day option for underwriters to purchase up to an additional 501,000 shares, less the underwriting discount.